DarioHealthDRIO
About: DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Employees: 252
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
1,850% more call options, than puts
Call options by funds: $117K | Put options by funds: $6K
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
8.99% less ownership
Funds ownership: 35.71% [Q2] → 26.72% (-8.99%) [Q3]
15% less funds holding
Funds holding: 39 [Q2] → 33 (-6) [Q3]
29% less capital invested
Capital invested by funds: $12.7M [Q2] → $8.98M (-$3.74M) [Q3]
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Research analyst outlook
We haven’t received any recent analyst ratings for DRIO.
Financial journalist opinion
Based on 6 articles about DRIO published over the past 30 days
